PRA Health Sciences Inc (PRAH):企業の財務・戦略的SWOT分析

◆英語タイトル:PRA Health Sciences Inc (PRAH) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C14818
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PRA Health Sciences Inc (PRA) is a contract research organization (CRO) which provides clinical development services. The company offers services which include phase I-IV study management, bioanalytical services, biometrics, clinical pharmacology, strategic solutions, post-marketing research, clinical diagnostics, pharmacovigilance, safety and risk management, and others. PRA spans its expertise in the therapeutic areas of oncology, hematology, respiratory, rare diseases, neurology, infectious diseases, cardio-metabolic, immunology, and vaccine solutions. It caters to pharmaceutical and biotechnology industries. The company has operations in the US, Hong Kong, Russia, India, France, Italy, China, Japan, South Africa, Israel and Colombia. PRA is headquartered in Raleigh, North Carolina, the US.

PRA Health Sciences Inc Key Recent Developments

Mar 04,2019: CISCRP and PRA Health Sciences Collaborate to Provide Clinical Trial Results Summaries to Patients and the Public
Feb 27,2019: PRA Health Sciences reports fourth quarter and full year 2018 results and provides first quarter and full year 2019 guidance
Feb 25,2019: PRA Health Sciences and CISCRP Collaborate to Provide Clinical Trial Results Summaries to Patients and the Public
Dec 13,2018: Symphony Health announces availability of 340B drug discount program data
Nov 29,2018: PRA Health Launches PSN to Expand in Pediatric Care, Stock Up

This comprehensive SWOT profile of PRA Health Sciences Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of PRA Health Sciences Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

PRA Health Sciences Inc – Key Information
PRA Health Sciences Inc – Overview
PRA Health Sciences Inc – Key Employees
PRA Health Sciences Inc – Key Employee Biographies
PRA Health Sciences Inc – Key Operational Heads
PRA Health Sciences Inc – Major Products and Services
PRA Health Sciences Inc – History
PRA Health Sciences Inc – Company Statement
PRA Health Sciences Inc – Locations And Subsidiaries
PRA Health Sciences Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

PRA Health Sciences Inc – Business Description
PRA Health Sciences Inc – Corporate Strategy
PRA Health Sciences Inc – SWOT Analysis
SWOT Analysis – Overview
PRA Health Sciences Inc – Strengths
PRA Health Sciences Inc – Weaknesses
PRA Health Sciences Inc – Opportunities
PRA Health Sciences Inc – Threats
PRA Health Sciences Inc – Key Competitors

Section 3 – Company Financial Performance Charts

PRA Health Sciences Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

PRA Health Sciences Inc, Key Information
PRA Health Sciences Inc, Key Ratios
PRA Health Sciences Inc, Share Data
PRA Health Sciences Inc, Major Products and Services
PRA Health Sciences Inc, History
PRA Health Sciences Inc, Key Employees
PRA Health Sciences Inc, Key Employee Biographies
PRA Health Sciences Inc, Key Operational Heads
PRA Health Sciences Inc, Other Locations
PRA Health Sciences Inc, Subsidiaries
PRA Health Sciences Inc, Key Manufacturing facilities
PRA Health Sciences Inc, Key Competitors
PRA Health Sciences Inc, SWOT Analysis
PRA Health Sciences Inc, Ratios based on current share price
PRA Health Sciences Inc, Annual Ratios
PRA Health Sciences Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

PRA Health Sciences Inc, Performance Chart
PRA Health Sciences Inc, Ratio Charts

★海外企業調査レポート[PRA Health Sciences Inc (PRAH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mentor Graphics Corporation:企業の戦略・SWOT・財務情報
    Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report Summary Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Neurocrine Biosciences Inc (NBIX):企業の財務・戦略的SWOT分析
    Neurocrine Biosciences Inc (NBIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Ebro Foods SA:企業のM&A・事業提携・投資動向
    Ebro Foods SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ebro Foods SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Care Hospitals:製薬・医療:M&Aディール及び事業提携情報
    Summary Care Hospitals is a healthcare service provider that offers medical care services. The center operates through its specialty departments such as anesthesiology, clinical psychology, obstetrics and gynecology, dietetics and nutrition, ophthalmology and hematology, emergency and general medici …
  • AbCheck sro:製薬・医療:M&Aディール及び事業提携情報
    Summary AbCheck Sro (AbCheck), a subsidiary of Affimed NV is a healthcare technology company offers discovery and optimization of high-quality human antibodies. The company offers technology platforms such as Absieve, and AbAccel. Its Absieve is an antibody discovery technology that offers proprieta …
  • Graphic Packaging Holding Company:企業のM&A・事業提携・投資動向
    Graphic Packaging Holding Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Graphic Packaging Holding Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Lancer Systems L.P.:企業の戦略・SWOT・財務情報
    Lancer Systems L.P. - Strategy, SWOT and Corporate Finance Report Summary Lancer Systems L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Premaitha Health Plc (NIPT):製薬・医療:M&Aディール及び事業提携情報
    Summary Premaitha Health Plc (Premaitha Health), formerly Vialogy Plc, is a molecular diagnostics company, which focuses on the development of genetic screening tests including novel tests for non-invasive prenatal screening (NIPT). Its flagship product, the IONA test is an advanced NIPT test that a …
  • Zhejiang Hisun Pharmaceutical Co Ltd (600267):企業の財務・戦略的SWOT分析
    Summary Zhejiang Hisun Pharmaceutical Co Ltd (Hisun) manufactures and commercializes drugs to treat tumor, infections, cardiovascular, endocrine, depression and orthopaedic disorders. The company’s product portfolio includes anti-tumor and anti-viral, hypoglycemic drugs, animal health products, oral …
  • Pakistan Services Ltd.
    Pakistan Services Ltd. - Strategy, SWOT and Corporate Finance Report Summary Pakistan Services Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Diebold Nixdorf Inc (DBD):企業の財務・戦略的SWOT分析
    Diebold Nixdorf Inc (DBD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Orcas Power & Light Cooperative:企業の戦略的SWOT分析
    Orcas Power & Light Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Amplifon SpA (AMP):企業の財務・戦略的SWOT分析
    Amplifon SpA (AMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • SkylineDx BV:企業の製品パイプライン分析
    Summary SkylineDx BV (SkylineDx) is a developer and commercializer of gene signature-based diagnostic tests for personalized medicine in oncology. The company offers MMprofiler and AMLprofiler molecular diagnostic tests for blood cancers. Its AMLprofiler is a vitro diagnostic test that recognizes ac …
  • Eagle Pharmaceuticals Inc (EGRX):製薬・医療:M&Aディール及び事業提携情報
    Summary Eagle Pharmaceuticals Inc (Eagle Pharma) is a specialty pharmaceutical company that offers proprietary pharmaceutical injectables in the therapy areas of critical care, oncology, and various orphan diseases. The company’s commercial product portfolio encompasses pharmaceutical injectables, i …
  • Keio University-製薬・医療分野:企業M&A・提携分析
    Summary Keio University (Keio) is an educational institution that offers academic and research in various fields. The university provides primary and secondary education, graduate and undergraduate courses, and information technology courses. It offers academic courses in the field of economics, law …
  • PerkinElmer, Inc.:企業の戦略・SWOT・財務情報
    PerkinElmer, Inc. - Strategy, SWOT and Corporate Finance Report Summary PerkinElmer, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • UCO Bank:戦略・SWOT・企業財務分析
    UCO Bank - Strategy, SWOT and Corporate Finance Report Summary UCO Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Isagen SA ESP:電力:M&Aディール及び事業提携情報
    Summary Isagen SA ESP (Isagen), a subsidiary of BRE Colombia Hydro Investments Limited, is an electricity utility that generates and markets electricity. It also supplies natural gas; and sells coal, steam, and other energy sources. The company produces electric energy from hydro and natural gas sou …
  • Japan Airlines Co Ltd:企業の戦略・SWOT・財務情報
    Japan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Japan Airlines Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆